TScan Therapeutics(TCRX) - 2023 Q2 - Quarterly Report
TScan Therapeutics(TCRX)2023-08-10 11:30UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to________________________ Commission File Number: 001-40603 TSCAN THERAPEUTICS, INC. (Exact name of ...